229 related articles for article (PubMed ID: 22104028)
1. Effect of single amino acid substitution on oxidative modifications of the Parkinson's disease-related protein, DJ-1.
Madian AG; Hindupur J; Hulleman JD; Diaz-Maldonado N; Mishra VR; Guigard E; Kay CM; Rochet JC; Regnier FE
Mol Cell Proteomics; 2012 Feb; 11(2):M111.010892. PubMed ID: 22104028
[TBL] [Abstract][Full Text] [Related]
2. Destabilization of DJ-1 by familial substitution and oxidative modifications: implications for Parkinson's disease.
Hulleman JD; Mirzaei H; Guigard E; Taylor KL; Ray SS; Kay CM; Regnier FE; Rochet JC
Biochemistry; 2007 May; 46(19):5776-89. PubMed ID: 17451229
[TBL] [Abstract][Full Text] [Related]
3. Formation of a stabilized cysteine sulfinic acid is critical for the mitochondrial function of the parkinsonism protein DJ-1.
Blackinton J; Lakshminarasimhan M; Thomas KJ; Ahmad R; Greggio E; Raza AS; Cookson MR; Wilson MA
J Biol Chem; 2009 Mar; 284(10):6476-85. PubMed ID: 19124468
[TBL] [Abstract][Full Text] [Related]
4. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization.
Canet-Avilés RM; Wilson MA; Miller DW; Ahmad R; McLendon C; Bandyopadhyay S; Baptista MJ; Ringe D; Petsko GA; Cookson MR
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9103-8. PubMed ID: 15181200
[TBL] [Abstract][Full Text] [Related]
5. Specific cleavage of DJ-1 under an oxidative condition.
Ooe H; Maita C; Maita H; Iguchi-Ariga SM; Ariga H
Neurosci Lett; 2006 Oct; 406(3):165-8. PubMed ID: 16935423
[TBL] [Abstract][Full Text] [Related]
6. Parkinson's disease-associated mutations in DJ-1 modulate its dimerization in living cells.
Repici M; Straatman KR; Balduccio N; Enguita FJ; Outeiro TF; Giorgini F
J Mol Med (Berl); 2013 May; 91(5):599-611. PubMed ID: 23183826
[TBL] [Abstract][Full Text] [Related]
7. Use of cysteine-reactive cross-linkers to probe conformational flexibility of human DJ-1 demonstrates that Glu18 mutations are dimers.
Prahlad J; Hauser DN; Milkovic NM; Cookson MR; Wilson MA
J Neurochem; 2014 Sep; 130(6):839-53. PubMed ID: 24832775
[TBL] [Abstract][Full Text] [Related]
8. The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein.
Zhou W; Zhu M; Wilson MA; Petsko GA; Fink AL
J Mol Biol; 2006 Mar; 356(4):1036-48. PubMed ID: 16403519
[TBL] [Abstract][Full Text] [Related]
9. Oxidation of DJ-1-dependent cell transformation through direct binding of DJ-1 to PTEN.
Kim YC; Kitaura H; Taira T; Iguchi-Ariga SM; Ariga H
Int J Oncol; 2009 Dec; 35(6):1331-41. PubMed ID: 19885556
[TBL] [Abstract][Full Text] [Related]
10. Separation of native and C106-oxidized DJ-1 proteins by using column chromatography.
Choi J; Yoo HJ; Cho K; Kim HN; Lee JH; Ryu KS
Protein Expr Purif; 2022 Aug; 195-196():106092. PubMed ID: 35430350
[TBL] [Abstract][Full Text] [Related]
11. Monomer DJ-1 and its N-terminal sequence are necessary for mitochondrial localization of DJ-1 mutants.
Maita C; Maita H; Iguchi-Ariga SM; Ariga H
PLoS One; 2013; 8(1):e54087. PubMed ID: 23326576
[TBL] [Abstract][Full Text] [Related]
12. Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases.
Choi J; Sullards MC; Olzmann JA; Rees HD; Weintraub ST; Bostwick DE; Gearing M; Levey AI; Chin LS; Li L
J Biol Chem; 2006 Apr; 281(16):10816-24. PubMed ID: 16517609
[TBL] [Abstract][Full Text] [Related]
13. Oxidized DJ-1 inhibits p53 by sequestering p53 from promoters in a DNA-binding affinity-dependent manner.
Kato I; Maita H; Takahashi-Niki K; Saito Y; Noguchi N; Iguchi-Ariga SM; Ariga H
Mol Cell Biol; 2013 Jan; 33(2):340-59. PubMed ID: 23149933
[TBL] [Abstract][Full Text] [Related]
14. DJ-1, a causative gene product of a familial form of Parkinson's disease, is secreted through microdomains.
Tsuboi Y; Munemoto H; Ishikawa S; Matsumoto K; Iguchi-Ariga SM; Ariga H
FEBS Lett; 2008 Jul; 582(17):2643-9. PubMed ID: 18586035
[TBL] [Abstract][Full Text] [Related]
15. Oxidizable residues mediating protein stability and cytoprotective interaction of DJ-1 with apoptosis signal-regulating kinase 1.
Waak J; Weber SS; Görner K; Schall C; Ichijo H; Stehle T; Kahle PJ
J Biol Chem; 2009 May; 284(21):14245-57. PubMed ID: 19293155
[TBL] [Abstract][Full Text] [Related]
16. Transnitrosylation from DJ-1 to PTEN attenuates neuronal cell death in parkinson's disease models.
Choi MS; Nakamura T; Cho SJ; Han X; Holland EA; Qu J; Petsko GA; Yates JR; Liddington RC; Lipton SA
J Neurosci; 2014 Nov; 34(45):15123-31. PubMed ID: 25378175
[TBL] [Abstract][Full Text] [Related]
17. Cysteine pKa depression by a protonated glutamic acid in human DJ-1.
Witt AC; Lakshminarasimhan M; Remington BC; Hasim S; Pozharski E; Wilson MA
Biochemistry; 2008 Jul; 47(28):7430-40. PubMed ID: 18570440
[TBL] [Abstract][Full Text] [Related]
18. Establishment of specific antibodies that recognize C106-oxidized DJ-1.
Ooe H; Iguchi-Ariga SM; Ariga H
Neurosci Lett; 2006 Aug; 404(1-2):166-9. PubMed ID: 16781058
[TBL] [Abstract][Full Text] [Related]
19. The role of cysteine oxidation in DJ-1 function and dysfunction.
Wilson MA
Antioxid Redox Signal; 2011 Jul; 15(1):111-22. PubMed ID: 20812780
[TBL] [Abstract][Full Text] [Related]
20. The E163K DJ-1 mutant shows specific antioxidant deficiency.
Ramsey CP; Giasson BI
Brain Res; 2008 Nov; 1239():1-11. PubMed ID: 18822273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
